Overall Rating
Stock is slightly underperforming.
Stock's dividend yield is adequate.
This rating is directly related to the length and consistency of a company's dividend payouts.
Dividend payouts are consistent, but increases small.
Earnings estimates are basically unchanged.
Recent Headlines
- Abbott Labs Numbers Make it a Force in the Stent Market (ABT)
Wed, Oct 15, 2008 - Abbott Labs to Purchase up to $5 Billion in Share Buyback Plan (ABT)
Mon, Oct 13, 2008 - 12 Dividend Stocks Removed from Our Recommended List
Thu, Oct 9, 2008 - Abbott Laboratories Reports Terrific Earnings (ABT)
Wed, Jul 16, 2008
Profile & Recommendation
Company Profile
Abbott Labs- (ABT) - A major diversified health care firm with significant positions in hospital and laboratory supplies, as well as baby formulas and nutritional products. ABT has a long-term record of sustained earnings growth, which should continue to rise by about 9-10% per year. Earnings in 1991 were 64¢ per share, which rose to $2.52 in 2006, while dividends have risen from 25¢ per share in 1991 to the present $1.44. The company was founded in 1888 and is based in Abbott Park, Illinois.
Based on our rating criteria, this stock has achieved a "Neutral" rating. Stocks with a neutral rating are considered mediocre investments in terms of expected price growth and dividend payments.
Stock Notes
This large cap stock is not an attractive dividend stock investment at this time.





Direct Competitors
RSS Feeds